Assessing the Effectiveness of Traditional Chinese Medicine as Neoadjuvant Therapy for Lowering Hepatocellular Carcinoma Risk in Patients with Hepatitis B-Induced Cirrhosis: A Systematic Review and Meta-Analysis · Peerford
Revisão · Revista · 2022
Assessing the Effectiveness of Traditional Chinese Medicine as Neoadjuvant Therapy for Lowering Hepatocellular Carcinoma Risk in Patients with Hepatitis B-Induced Cirrhosis: A Systematic Review and Meta-Analysis